Christopher W Ryan - Oregon Health and Science University Knight Cancer Institute

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 319 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

A Phase II Basket Trial of Dual Anti-Ctla-4 and Anti-Pd-1 Blockade in Rare Tumors (DART) SWOG S1609: Durable Responses and Delayed Pseudoprogression in Small Cell Carcinoma of the Ovary, Hypercalcemic Type Cohort

Young Kwang Chae,Megan Othus, Sandip Pravin Patel, Raid Aljumaily, Khine Z Win, Tanya Pejovic, Sajeve S Thomas,William R Robinson, Hye Sung Kim, Liam Il-Young Chung, Christine M McLeod,Helen X Chen,Elad Sharon,Howard Streicher,Christopher W Ryan,Charles D Blanke,Razelle Kurzrock

Cancer communications (London, England) (2025)

Cited0Views0WOSBibtex

Ribociblib in Sequential Combination with Doxorubicin in Anthracycline-Naive Advanced Soft Tissue Sarcomas: Results of a Dose-Finding Phase 1B Study

Lara E Davis, Limin Zhu,Emile Latour, Nathan McMahon, Go Nishikawa, Florence Choo, Kevin D Nusser,Janét Pittsenbarger, Reid Burch,Byung Park, Gordon B Mills,Jessica L Davis, Monika Davare,Christopher W Ryan

Clinical cancer research an official journal of the American Association for Cancer Research (2025)

Cited0Views0WOSBibtex

Dual Anti-Ctla-4 and Anti-Pd-1 Blockade in Metastatic Basal Cell Carcinoma

Sandip P. Patel, Eleanor Cano-Linson,Young Kwang Chae,Shiruyeh Schokrpur,Christopher D. Lao,Benjamin C. Powers,Adrienne I. Victor,Adedayo A. Onitilo,Sarah Shin,Naoko Takebe, Sara Threlkel,Christine M. McLeod,Helen X. Chen,Elad Sharon,Megan Othus,Christopher W. Ryan,Charles D. Blanke,Razelle Kurzrock

npj Precision Oncologyno. 1 (2025): 1-7

Cited0Views0WOSNATUREBibtex

1690O NKT2152, a Novel Oral HIF-2α Inhibitor, in Participants (pts) with Previously Treated Advanced Clear Cell Renal Carcinoma (accrcc): Preliminary Results of a Phase I/II Study

E. Jonasch,B.A. McGregor,P. Msaouel, T. Logan, E.T. Hall,M.A. Bilen,G.S. Falchook,B. Shuch,Y. Zakharia, R. Hauke,M. Gordon,A-R. Naqash,C.W. Ryan, R. Srinivasan, J. Xiao, W. Sun, M. Esguerra, G. Lu, J. Lager,T.K. Choueiri

Annals of Oncology（2024）

Cited0Views0Bibtex

A Phase II Basket Trial of Dual Anti-Ctla-4 and Anti-Pd-1 Blockade in Rare Tumors (DART) SWOG S1609: Sarcomatoid Carcinoma of Lung (cohort 11)

Young Kwang Chae,Megan Othus,Sandip Patel, Peeran Sandhu, Larry R. Corum, Jeremy P. Cetnar, Shayan Rayani,Anna Moseley,Liam Il-Young Chung,Hye Sung Kim,Christine M. McLeod,Helen X. Chen,Elad Sharon,Howard Streicher,Christopher W. Ryan,Charles D. Blanke,Razelle Kurzrock

CANCER RESEARCHno. 7 (2024)

Cited0Views0Bibtex

Abstract CT262: A Phase II Basket Trial of Dual Anti-Ctla-4 and Anti-Pd-1 Blockade in Rare Tumors (DART) SWOG S1609: Sarcomatoid Carcinoma of Lung (cohort 11)

Cancer Researchno. 7_Supplement (2024)

Cited0Views0Bibtex

Supplementary Table S2 from SWOG/NCI Phase II Dual Anti–CTLA-4/PD-1 Blockade in Rare Tumors: Nonepithelial Ovarian Cancer

Young Kwang Chae,Megan Othus,Sandip Pravin Patel,Kelly J. Wilkinson, Emily M. Whitman-Purves,Jayanthi Lea, John M. Schallenkamp,Nabil Adra,Leonard J. Appleman, Mitchell Alden, Jessica Thomes Pepin, John A. Ellerton,Andrew Poklepovic,Adam Walter,Murtuza M. Rampurwala,William R. Robinson,Hye Sung Kim,Liam Il-Young Chung,Christine M. McLeod,Gabby Lopez,Helen X. Chen,Elad Sharon,Howard Streicher,Christopher W. Ryan,Charles D. Blanke,Razelle Kurzrock

crossref（2024）

Cited0Views0Bibtex

58MO Evaluation of Three Pexidartinib Doses in a Global Phase IV Clinical Study of Patients with Tenosynovial Giant Cell Tumor (TGCT) Who Chose to Continue Treatment

S. Stacchiotti,A.J. Wagner,I.C. Carrasco Garcia,M. Cesari,M. Gordon,C-C. Lin,Z. Papai,C.W. Ryan,W.D. Tap,J.C. Trent,H. Gelderblom,P. Grimison,A. Lopez Pousa,B.A. Van Tine, M. Rubinacci,K. Tecson,M. Wooddell,J. Desai

ESMO Open (2024): 102448

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn